SCHEMBL7904237

SCHEMBL7904237

CCc1cccc(N2CCOC2=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.50
HTR1A P08908 2/20 0.48
HTR1D P28221 2/20 0.48
HTR1B P28222 2/20 0.48
DRD2 P14416 1/20 0.48
HTR2A P28223 1/20 0.48
HTR7 P34969 1/20 0.48
DRD3 P35462 1/20 0.48
HTR2B P41595 1/20 0.48
HTR6 P50406 1/20 0.48
KCNH2 Q12809 1/20 0.48
ALOX5 P09917 1/20 0.48
GRM2 Q14416 1/20 0.43
KDM1A O60341 2/20 0.41
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
KDM1B Q8NB78 2/20 0.41
RCOR1 Q9UKL0 2/20 0.41
SLC9A3 P48764 1/20 0.41
NAAA Q02083 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13853420 0.85 HTR1A (0.46) HTR1AHTR1DHTR1BDRD2HTR2A
SCHEMBL4018668 0.85 HTR1A (0.46) HTR1AHTR1DHTR1BDRD2HTR2A
SCHEMBL2883416 0.84 HTR1A (0.45) HTR1AHTR1DHTR1BDRD2HTR2A
Hydrochloric Acid SCHEMBL4234312 0.84 HTR1A (0.45) HTR1AHTR1DHTR1BDRD2HTR2A
SCHEMBL2885518 0.83 NAAA (0.48) HTR1AHTR1DHTR1BDRD2HTR2A
SCHEMBL2882743 0.82 HTR1A (0.49) HTR1AHTR1DHTR1BDRD2HTR2A
SCHEMBL8413923 0.82 HTR1A (0.49) HTR1AHTR1DHTR1BDRD2HTR2A
SCHEMBL7902662 0.81 MGLL (0.44) MGLLGRM2KDM1AMAOAMAOB
SCHEMBL10191867 0.80 HSD11B1 (0.55) MGLLDRD2DRD3ALOX5GRM2
SCHEMBL30669238 0.80 HSD11B1 (0.55) MGLLDRD2DRD3ALOX5GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373634-B1 MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS MOCHIDA PHARM CO LTD (JP) 2015-11-11 EP disclosed
US-20110135650-A1 MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS MERCK SHARP & DOHME LLC 2011-06-09 US disclosed
WO-2010065717-A1 MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110135650-A1 MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS SERPINC1, F9, F8 MGLL 1949/4885HTR1A 4306/4885HTR1D 4621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.